QR-110

· Laboratoires Thea

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QR-110, covering 2022-12-27 to 2022-12-27. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate QR-110 in Leber's Congenital Amaurosis (LCA) Due to the c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene [Phase 1, Phase 2]

See pricing